CoreValve Expands Percutaneous Aortic Valve Trial In Europe
This article was originally published in The Gray Sheet
Executive Summary
CoreValve plans to begin a 250-patient European pivotal trial of its ReValving self-expanding percutaneous aortic valve replacement system by year-end